Efficacy, safety, and dose selection of efepoetin alfa in anemic patients on maintenance dialysis: a phase 2, randomized, multicenter, active-controlled trial.
- DOI
- 10.23876/j.krcp.26.080
- Published
- 2026 Sep
- Container
- Kidney research and clinical practice
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.23876/j.krcp.26.080,
title = {Efficacy, safety, and dose selection of efepoetin alfa in anemic patients on maintenance dialysis: a phase 2, randomized, multicenter, active-controlled trial.},
author = {Ko EJ and Byun MS and Yang CW and Shin SK and Kim HW and Shin BC and Shin SJ and Park HC and Kang YS and Lee SH and Song HC and Kim SH and Na KY and Jo YI and Kim W and Seong EY and Kim YL and Ryu H and Kim H and Choi YJ and Chung BH},
year = {2026},
journal = {Kidney research and clinical practice},
doi = {10.23876/j.krcp.26.080},
url = {https://doi.org/10.23876/j.krcp.26.080}
}RIS
TY - JOUR TI - Efficacy, safety, and dose selection of efepoetin alfa in anemic patients on maintenance dialysis: a phase 2, randomized, multicenter, active-controlled trial. AU - Ko EJ AU - Byun MS AU - Yang CW AU - Shin SK AU - Kim HW AU - Shin BC AU - Shin SJ AU - Park HC AU - Kang YS AU - Lee SH AU - Song HC AU - Kim SH AU - Na KY AU - Jo YI AU - Kim W AU - Seong EY AU - Kim YL AU - Ryu H AU - Kim H AU - Choi YJ AU - Chung BH PY - 2026 JO - Kidney research and clinical practice DO - 10.23876/j.krcp.26.080 UR - https://doi.org/10.23876/j.krcp.26.080 ER -
APA
EJ, K., MS, B., CW, Y., SK, S., HW, K., BC, S., SJ, S., HC, P., YS, K., SH, L., HC, S., SH, K., KY, N., YI, J., W, K., EY, S., YL, K., H, R., H, K., YJ, C., & BH, C. (2026). Efficacy, safety, and dose selection of efepoetin alfa in anemic patients on maintenance dialysis: a phase 2, randomized, multicenter, active-controlled trial.. Kidney research and clinical practice. https://doi.org/10.23876/j.krcp.26.080
Source records
- pubmed · retrieved 2026-09-26T09:59:04.578Z